PSA Levels

Posts Tagged ‘screening’

Dr. David Samadi clarifies confusion surrounding the new government recommendation that healthy men forgo PSA screening. As he explains, the panel’s decision is based on older studies of older men, rather than newer studies of younger men – the group most likely to benefit from PSA tests. Since 1990, prostate cancer deaths have decreased 40% as a result of early prostate cancer testing and early diagnosis. Dr. Samadi stresses the need for individualized care explaining that testing healthy, younger men allows them to establish a PSA baseline, from which annual PSA screenings can monitor changes referred to as the PSA velocity.

Are there modifiable risk factors for prostate cancer? Nutrition? Environment? June Chan, UCSF Division of Cancer Epidemiology, explores the nutritional and hormonal risk factors for prostate cancer. Series: UCSF Mini Medical School for the Public [2/2009] [Health and Medicine] [Show ID: 15574]

Following new anti-PSA recommendations from a US government task force, Dr. David Samadi and other prostate cancer specialists are speaking out in support of annual PSA screening. They believe PSA tests are the best line of defense against prostate cancer, proven by the drop in prostate cancer deaths over the past 15 years. A prostate cancer survivor shares how a routine PSA and early detection saved his life.

If you’re a male over the age of 40, African American or have a family history of prostate cancer – you’re more at risk for developing it. Dr. Paul goes over the tests and procedures to help detect prostate cancer including digital screenings, PSA test and biopsies. For more information visit: video.healthination.com

Tim Glynn discusses his experience with the PSA screening and what patients should know before deciding to have the screening. Tim Glynn, a lawyer from Setauket, NY, was 47 years old in 1997 when he went to his primary-care doctor, troubled by a vague feeling of being down. After his physical exam, Glynn was sent to have his blood drawn. Along with thyroid and cholesterol level testing, the doctor ordered a PSA test. A week later, Glynn returned to hear the results. His PSA was elevated. He was told to get a biopsy as soon as possible. This is his personal story as to what he believes patients should know about the PSA test. He is not a medical professional and his opinions are his own. The Foundation for Informed Medical Decision Making believes that PSA screening should be made in the context of a shared medical decision. Shared medical decision making allows patients and their providers to make treatment decisions together, taking into the account the best scientific evidence available as well as the patients’ values and preferences.

Product Description
This digital document is an article from Duke Medicine Health News, published by Belvoir Media Group, LLC on July 1, 2009. The length of the article is 712 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Screening for prostate cancer still a gray area: study findings raise questions about whether or not the PSA test saves lives.(CANCER)
Author: Unavailable
Publication: Duke Medicine Health News (Newsletter)
Date: July 1, 2009
Publisher: Belvoir Media Group, LLC
Volume: 15 Issue: 7 Page: 6(2)

Distributed by Gale, a part of Cengage Learning

Screening for prostate cancer still a gray area: study findings raise questions about whether or not the PSA test saves lives.: An article from: Duke Medicine Health News

Dr. David Samadi, member of the Fox News Medical “A-Team” and Vice Chair of Urology at Mt. Sinai Medical Center in New York, discusses his thoughts on a new study in the British Medical Journal that states that there is no benefit to prostate cancer screening. Dr. Samadi feels that there is a definite benefit to screening, and that the data used for this study is faulty due to the lack of standardized PSA testing during its first six years. He also places emphasis on doctors looking at several factors that help determine whether a patient is at risk of prostate cancer. This includes not only PSA level, but watching PSA velocity (the rate at which PSA levels rise over time), and paying attention to a patient’s family history, as there is a strong genetic link to prostate cancer developing. When caught early, prostate cancer has a very high cure rate. However, if it is not treated and it spreads to the bone then treatment becomes incredibly difficult. This is why Dr. Samadi feels that carefully monitoring each patient on an individual basis and paying attention to the risk factors involved in each case, along with PSA screening, is an incredibly beneficial process. Toview more health-related videos by Dr. Samadi on YouTube please follow this link: www.youtube.com You can also visit Dr. Samadi’s website at: www.roboticoncology.com To sign up for Dr. Samadi’s monthly newsletter please follow this link: www.roboticoncology.com To read Dr. Samadi’s blogs please follow these …

This patient education video explains the PSA blood test for prostate cancer. The program covers anatomy, symptoms and their causes, and the PSA test and its possible results. The program extensively discusses what to expect after the results of the PSA test have been returned.

LATEST NEWS IN ACTION www.seechannel9.webs.com , thelatest news, financial crisis ,housing crisis ,stockmarket crisis , layoffs, recession, unemployment rate, job search ,economic tsunami , recovery plan , stimulus , bailout ,bonus outrage .ZHU ZHU PET HAMSTERS ARE IN STOCK HERE: www.buy.com llow/q/loc/20269/213266281.html www.entertainmentearth.com www.blinkx.com www.freewebs.com

Dr. Siegel explains the PSA (Prostate Specific Antigen) test used to screen for and monitor prostate cancer